What Is The Forecast Valuation Of The Cell Therapy Human Raw Materials Market Projected To Reach $6.67 Billion By 2029?
Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
What Are The Future Growth Projections For The Cell Therapy Human Raw Materials Market Size?
The market size for human raw materials for cell therapy has seen considerable expansion in the recent past. The market is projected to rise from $2.82 billion in 2024 to $3.36 billion in 2025, registering a compound annual growth rate (CAGR) of 19.3%. Factors contributing to this growth during the historical period include an increase in chronic disease cases, an aging population, a heightened need for regenerative treatments, supportive government funding, and an escalation in healthcare spending.
The market size for human raw materials in cell therapy is projected to experience a swift expansion in the forthcoming years, increasing to “$6.67 billion by 2029”, with a compound annual growth rate (CAGR) of 18.7%. This surge during the forecast period can be credited to factors such as broader therapeutic usage, increased awareness among patients, supportive regulatory policies, the expansion of the biopharmaceutical sector, and enhancements in manufacturing methods. Key trends projected in this period include the acceptance of allogeneic therapies, inclusion of artificial intelligence, growth in off-the-shelf cell therapies, implementation of 3D bioprinting technology, and progress in hybrid cell therapies.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15759&type=smp
What Market Forces Are Contributing To The Growth Of The Cell Therapy Human Raw Materials Market?
Cell therapy human raw materials market growth is expected to be fueled by the increasing adoption of regenerative medicine. This field of medicine leverages the body’s natural regenerative capabilities or employs external factors like stem cells, tissue engineering, or gene therapy to repair or regenerate damaged body tissues and organs, with a goal to restore their normal functioning. The growth of regenerative medicine has been spurred by developments in biotechnology, heightened understanding of cellular mechanisms, increasing demand for personalized medical care, and its potential to cater to unmet medical requirements more effectively. Cell therapy, along with human raw materials, enhances the adoption of regenerative medicine by supplying critical biological aspects required for cell-centred treatments. This allows the creation of uniform and dependable treatment techniques for a range of diseases. A report by the Alliance for Regenerative Medicine, a not-for-profit organization based in the US, stated that by August 2023 there were 2760 developers globally of cell, gene, and tissue-engineering therapeutics in the first quarter of 2023, an increase of 101% compared to 1369 in the same quarter of 2022. Consequently, the growing adoption of regenerative medicine propels the expansion of the cell therapy human raw materials market.
How Is The Cell Therapy Human Raw Materials Market Segmented Across Key Categories?
The cell therapy human raw materials market covered in this report is segmented –
1) By Product: Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials
2) By Type Of Cell Therapy: Dendritic Cell Therapy, Natural Killer (NK) Cell Therapy, Stem Cell Therapy, T-Cell Therapy
3) By End-Use: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs), Academic And Research Institutions
Subsegments:
1) By Cell Culture Media: Serum-Free Media, Serum-Based Media, Defined Media, Specialized Media (E.G., For Stem Cells)
2) By Cell Culture Sera: Fetal Bovine Serum (FBS), Human Serum, Adult Bovine Serum
3) By Cell Culture Supplements: Growth Factors, Cytokines, Peptides
4) By Reagents And Buffers: Enzymes (E.G., Trypsin), Ph Buffers, Cryoprotectants
5) By Other Raw Materials: Cell-Free DNA, Plasma And Platelet-Rich Plasma (PRP), Vials And Storage Containers
What Key Trends Are Driving Growth In The Cell Therapy Human Raw Materials Market?
Significant players in the cell therapy human raw materials market are increasingly centering their efforts on the creation of chemically defined cell culture mediums in order to expedite the development of cell therapy. A cell culture medium, nourishing solution rich in essential nutrients, growth factors, and environmental conditions, is crucial for in vitro growth and propagation of cells outside their natural surroundings. For instance, in May 2023, the Switzerland-based healthcare manufacturing company Lonza Group AG introduced the TheraPEAK T-VIVO Cell Culture Medium. This product release features a chemically defined formulation that is devoid of serum or animal component, recombinant proteins, and offers enhanced culture and expansion support, as well as application help, ensuring consistency, safety, and regulatory compliance in cell therapy manufacturing. This medium is a huge leap forward technologically, with its elimination of animal ingredients, chemically defined formulation, and features favorable to regulation, thereby enhancing safety, quality, and regulatory compliance.
Which Firms Are Driving Innovation Within The Cell Therapy Human Raw Materials Market?
Major companies operating in the cell therapy human raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE Healthcare, Corning Incorporated, Lonza Group Ltd., Grifols S.A., WuXi AppTec, Catalent Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Pall Corporation, Bio-Techne Corporation, Miltenyi Biotec, Actylis, STEMCELL Technologies, Takara Bio Inc., Vericel Corporation, ACROBiosystems, BioIVT LLC, Orgenesis Inc., PromoCell GMBH, ViaCyte Inc., AllCells LLC, Sartorius CellGenix GmbH, Fujifilm Cellular Dynamics Inc., Mesoblast Limited, RoosterBio Inc., Thermogenesis Holdings Inc.
Access The Complete Report Here:
How Do Regional Dynamics Influence The Cell Therapy Human Raw Materials Market Performance?
North America was the largest region in the cell therapy human raw materials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy human raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15759&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
